Morgan Stanley has lowered its price target on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) to $755 from $958, while ...

Piper Sandler analyst Michael Lavery has raised the firm’s price target on Celsius Holdings, Inc. (NASDAQ:CELH) to $45 from ...

Cantor Fitzgerald analysts reaffirmed their price target of $71 and Overweight rating on CVS Health Corporation (NYSE:CVS) on ...

On Friday, Piper Sandler analysts reiterated their Overweight rating for BridgeBio Pharma (NASDAQ:BBIO) stock, maintaining a price target of $63.00. The stock has shown remarkable momentum ...

InvestingPro analysis reveals the company maintains a "GREAT" overall financial ... Barclays downgraded Centene's stock from Overweight to Equalweight, citing concerns in the Part D and Affordable ...

Piper Sandler lifted the price target on NVIDIA Corporation (NASDAQ:NVDA) stock from $150 to $180, reaffirming its Overweight ...

Morgan Stanley lifted NVIDIA Corporation (NASDAQ:NVDA)’s stock price target to $170 from $160, while maintaining an Overweight rating for its shares. The firm’s analyst expressed optimism about the ...

Obesity — like most other medical conditions — requires an “arsenal” of treatments, rather than a one-size-fits-all approach.

Matt Miksic from Barclays lowered the price target on Becton, Dickinson, and Company (NYSE:BDX) from $261 to $241, while ...

Morgan Stanley maintains an 'overweight' rating on Trent with a target price of Rs 6,359. The brokerage highlights Trent's ...

Attrition rates in IT Services may not rise further, while other growth drivers may persist. The brokerage lowered estimates ...

Tuesday saw UnitedHealth Group (NYSE: UNH) shares remain under the spotlight as Piper Sandler reiterated an Overweight rating with a price target of $552.00.The $285 billion healthcare giant, ...